gentian violet has been researched along with Disease Models, Animal in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Batista, R; Chiari, E; de Oliveira, AB; Humberto, JL | 1 |
| Alves Lima, FC; Ferreira da Silva, AB; Gutierrez, FR; Nogueira Silva, JJ; Pavanelli, WR; Santana Silva, J; Wagner Franco, D | 1 |
| de Simone, CA; dos Santos Filho, JM; Ferreira, RS; Guimarães, ET; McKerrow, JH; Meira, CS; Moreira, DR; Soares, MB | 1 |
| Anjos, PS; Cerqueira, JV; da Silveira, RG; Dias Neto, HA; Dos Santos Filho, JM; Meira, CS; Moreira, DRM; Queiroz, EF; Russo, HM; Soares, MBP; Sousa, CC; Wolfender, JL | 1 |
| Lin, R; Liu, C; Piao, M; Song, Y | 1 |
| Arbiser, JL | 1 |
| Franco, DW; Osakabe, AL; Pavanelli, WR; Silva, JJ; Silva, JS | 1 |
| Chang, SM; Chung, LW; Degeorges, A; Ozen, M; Pathak, S; Sikes, RA; Thalmann, GN; Wu, TT | 1 |
9 other study(ies) available for gentian violet and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Synthesis and trypanocidal activity of ent-kaurane glycosides.
Topics: Animals; Disease Models, Animal; Diterpenes, Kaurane; Glycosides; Male; Mice; Molecular Conformation; Parasitic Sensitivity Tests; Stereoisomerism; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma cruzi | 2007 |
Complexation of the anti-Trypanosoma cruzi drug benznidazole improves solubility and efficacy.
Topics: Animals; Chagas Disease; Disease Models, Animal; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred BALB C; Nitroimidazoles; Spectrophotometry, Ultraviolet; Trypanocidal Agents; Trypanosoma cruzi | 2008 |
Optimization of anti-Trypanosoma cruzi oxadiazoles leads to identification of compounds with efficacy in infected mice.
Topics: Animals; Antiprotozoal Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Mice; Mice, Inbred BALB C; Models, Molecular; Molecular Structure; Oxadiazoles; Parasitic Sensitivity Tests; Structure-Activity Relationship; Trypanosoma cruzi; Trypanosomiasis | 2012 |
Structural design, synthesis and substituent effect of hydrazone-N-acylhydrazones reveal potent immunomodulatory agents.
Topics: Animals; Anti-Inflammatory Agents; Cell Survival; Crystallography, X-Ray; Dinoprostone; Disease Models, Animal; Drug Design; G1 Phase Cell Cycle Checkpoints; Hydrazones; Immunologic Factors; Interleukin-1beta; Lipopolysaccharides; Macrophages, Peritoneal; Male; Mice; Mice, Inbred BALB C; Molecular Conformation; Nitric Oxide; Peritonitis; Structure-Activity Relationship | 2018 |
Quercetin Suppresses AOM/DSS-Induced Colon Carcinogenesis through Its Anti-Inflammation Effects in Mice.
Topics: Animals; Antineoplastic Agents; Azoxymethane; Biomarkers, Tumor; Carcinogenesis; Colon; Colorectal Neoplasms; Dextran Sulfate; Disease Models, Animal; Gene Expression Regulation, Neoplastic; Gentian Violet; Humans; Hydroxybutyrates; Mice; Mice, Inbred C57BL; Oxidative Stress; Quercetin; Tumor Burden | 2020 |
Gentian violet is safe.
Topics: Animals; Cohort Studies; Disease Models, Animal; Drug-Related Side Effects and Adverse Reactions; Gentian Violet; Humans; Leukoplakia, Hairy; Mice; Risk Assessment; Sensitivity and Specificity | 2009 |
In vitro and in vivo antiproliferative and trypanocidal activities of ruthenium NO donors.
Topics: Animals; Chagas Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Gentian Violet; Heart; Inhibitory Concentration 50; Mice; Myocardium; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; Parasitemia; Parasitic Sensitivity Tests; Ruthenium Compounds; Trypanocidal Agents; Trypanosoma cruzi | 2007 |
LNCaP progression model of human prostate cancer: androgen-independence and osseous metastasis.
Topics: Animals; Blotting, Northern; Bone Neoplasms; Cell Line; Dihydrotestosterone; Disease Models, Animal; Gene Expression Regulation, Neoplastic; Gentian Violet; Histocytochemistry; Humans; Image Processing, Computer-Assisted; Immunoenzyme Techniques; Karyotyping; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Orchiectomy; Osteosarcoma; Prostate-Specific Antigen; Prostatic Neoplasms; RNA, Neoplasm; Specific Pathogen-Free Organisms; Tumor Cells, Cultured | 2000 |